Hey, Steve
Will nicotine affect the moa of this product as it does with Evomuse's?
For anyone reading, when I say BMP, I mean bone morphogenetic protein, I'm not referring to the product named BMP.
Please correct me if I'm wrong, but isn't it their stance that nicotine may limit the effectiveness of their product, but that there is no side effect or health concern? As in basically, it isn't going to hurt to use nicotine with it, but that a person that doesn't use nicotine may get better results from theirs?
Nicotine in general has been shown to have a negative effect on bone formation and bone morphogenetic protein, but that's nothing specific to any product - its an action that nicotine has on a nicotine user in their life every day anyway.
My thought on this is that its possible that a person that uses nicotine may not experience as good of results as their non-nicotine using counterpart, but they should still experience results because in theory their level of BMP expression and activity would be reduced in their day to day life anyway bc of using nicotine.
For example, non-nicotine user John Doe1 on average would have better BMP activity and expression than nicotine user John Doe2. So if John Doe1 experiences a 30% increase in BMP activity and expression (not real % increase, just an example) and John Doe2 experiences only a 20% increase, then even though the % increase isn't as much as John Doe1, its still 20% more than John Doe2 had before.
I hope I explained that in a way that makes sense.
It's important to clarify that the product we are coming out with that will have very potent BMP enhancing components, but that is just one of the methods of action for the product; there will be a lot more to it than just that.